Literature DB >> 23960711

Preparation and comparative evaluation of sustained release metoclopramide hydrochloride matrix tablets.

Sayed I Abdel-Rahman1, Gamal M Mahrous, Mahmoud El-Badry.   

Abstract

Metoclopramide hydrochloride (MCP) is commonly used for the management of gastrointestinal disorders. Frequent administration and the undesired side effects (extra pyramidal symptoms) of the drug on the central nervous system due to the fluctuations of its plasma concentrations may lead to patient incompliance, and hence, improper therapy. Therefore, the present work will be devoted to formulate the drug in sustained release formulations. MCP was incorporated in 12 formulae containing different polymers and/or different polymer ratios. These polymers were hydroxypropylmethyl cellulose (HPMC), carboxymethylcellulose (CMC) and ethyl cellulose (EC). Sodium starch glycolate (SSG) was added to some formulae in different amounts in order to soften and/or disintegrate the tablets. Both direct compression and granulation techniques were used to prepare the tablets. The physical properties were found to be satisfactory for all the formulae. The dissolution profiles of the tablets were constructed using the change-over method. The drug release involved a combination of both diffusion and polymer-chain relaxation mechanisms. The time required to release 50% of MCP ranged from 1.2 to more than 8 h. Direct compression and dry granulation techniques produced sufficient sustaining of the drug release. However, the pellets made by wet granulation released MCP in about 2 h, i.e., pelletization spheronization technique was not effective in sustaining the drug.

Entities:  

Keywords:  Cellulosic polymers; Metoclopramide; Release kinetics; Super disintegrant; Sustained release; Tablet making techniques

Year:  2009        PMID: 23960711      PMCID: PMC3730993          DOI: 10.1016/j.jsps.2009.10.004

Source DB:  PubMed          Journal:  Saudi Pharm J        ISSN: 1319-0164            Impact factor:   4.330


  7 in total

1.  Release performance of a poorly soluble drug from a novel, Eudragit-based multi-unit erosion matrix.

Authors:  K A Mehta; M S Kislalioglu; W Phuapradit; A W Malick; N H Shah
Journal:  Int J Pharm       Date:  2001-02-01       Impact factor: 5.875

2.  MECHANISM OF SUSTAINED-ACTION MEDICATION. THEORETICAL ANALYSIS OF RATE OF RELEASE OF SOLID DRUGS DISPERSED IN SOLID MATRICES.

Authors:  T HIGUCHI
Journal:  J Pharm Sci       Date:  1963-12       Impact factor: 3.534

3.  Bioavailability of controlled-release metoclopramide. 1st communication: single dose study.

Authors:  A H Beckett; W A Behrendt; B W Hadzija
Journal:  Arzneimittelforschung       Date:  1987-02

4.  The gastroprokinetic and antiemetic drug metoclopramide is a substrate and inhibitor of cytochrome P450 2D6.

Authors:  Zeruesenay Desta; G M Wu; A M Morocho; D A Flockhart
Journal:  Drug Metab Dispos       Date:  2002-03       Impact factor: 3.922

5.  Chitosan and chondroitin microspheres for oral-administration controlled release of metoclopramide.

Authors:  A Ganza-González; S Anguiano-Igea; F J Otero-Espinar; J Blanco Méndez
Journal:  Eur J Pharm Biopharm       Date:  1999-09       Impact factor: 5.571

6.  The effect of hydrophilic and lipophilic polymers and fillers on the release rate of atenolol from HPMC matrices.

Authors:  F Lotfipour; A Nokhodchi; M Saeedi; S Norouzi-Sani; J Sharbafi; M R Siahi-Shadbad
Journal:  Farmaco       Date:  2004-10

7.  Assessment of a controlled release hydrophilic matrix formulation for metoclopramide HCl.

Authors:  Enas I Hasan; Bassam I Amro; Tawfiq Arafat; Adnan A Badwan
Journal:  Eur J Pharm Biopharm       Date:  2003-05       Impact factor: 5.571

  7 in total
  4 in total

1.  Evaluation of Prosopis africana Seed Gum as an Extended Release Polymer for Tablet Formulation.

Authors:  Sameer Nadaf; Petra Nnamani; Namdeo Jadhav
Journal:  AAPS PharmSciTech       Date:  2014-12-19       Impact factor: 3.246

2.  Design, Formulation and In Vitro Evaluation of Sustained-release Tablet Formulations of Levosulpiride.

Authors:  Muhammad Samie; Sajid Bashir; Jabbar Abbas; Samiullah Khan; Nargis Aman; Habibullah Jan; Naveed Muhammad
Journal:  Turk J Pharm Sci       Date:  2018-11-20

3.  The Role of Nanoparticle in Brain Permeability: An in-vitro BBB Model.

Authors:  Niusha Nikandish; Leila Hosseinzadeh; Abbas Hemati Azandaryani; Katayoun Derakhshandeh
Journal:  Iran J Pharm Res       Date:  2016       Impact factor: 1.696

4.  Use of response surface methodology in the formulation and optimization of bisoprolol fumarate matrix tablets for sustained drug release.

Authors:  Jadupati Malakar; Amit Kumar Nayak; Soumita Goswami
Journal:  ISRN Pharm       Date:  2012-12-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.